The expression of the CD44 variant 8–10 (CD44v8-10) on the cell surface stabilizes xCT (a cystine-glutamate transporter) and contributes to glutathione (GSH) synthesis for ROS defense, leading to redox regulation in several cancers [12, 14, 20]. Here, SLC7A11 is linked to cancer.